ΔBAFF, a splice isoform of BAFF, opposes full-length BAFF activity in vivo in transgenic mouse models

被引:88
作者
Gavin, AL
Duong, B
Skog, P
Aït-Azzouzene, D
Greaves, DR
Scott, ML
Nemazee, D
机构
[1] Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA
[2] Scripps Res Inst, Kellogg Sch Sci & Technol, Doctoral Program Chem & Biol Sci, La Jolla, CA 92037 USA
[3] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 2JD, England
[4] Biogen Idec Inc, Cambridge, MA 02142 USA
关键词
D O I
10.4049/jimmunol.175.1.319
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Delta BAFF is a novel splicing isoform of the regulator B cell-activating factor (BAFF, BLyS), a TNF family protein with powerful immunoregulatory effects. Overexpression of BAFF leads to excessive B cell accumulation, activation, autoantibodies, and lupus-like disease, whereas an absence of BAFF causes peripheral B cell immunodeficiency. Based on the ability of Delta BAFF to multimerize with full-length BAFF and to limit BAFF proteolytic shedding from the cell surface, we previously proposed a role for Delta BAFF in restraining the effects of BAFF and in regulating B lymphocyte homeostasis. To test these ideas we generated mice transgenic for Delta BAFF under the control of human CD68 regulatory elements, which target expression to myeloid and dendritic cells. We also generated in parallel BAFF transgenic mice using the same expression elements. Analysis of the transgenic mice revealed that Delta BAFF and BAFF had opposing effects on B cell survival and marginal zone B cell numbers. Delta BAFF transgenic mice had reduced B cell numbers and T cell-dependent Ab responses, but normal preimmune serum Ig levels. In contrast, BAFF transgenic mice had extraordinarily elevated Ig levels and increases in subsets of B cells. Unexpectedly, both BAFF and-Delta BAFF appeared to modulate the numbers of B-1 phenotype B cells.
引用
收藏
页码:319 / 328
页数:10
相关论文
共 51 条
  • [1] BAFF mediates survival of peripheral immature B lymphocytes
    Batten, M
    Groom, J
    Cachero, TG
    Qian, F
    Schneider, P
    Tschopp, J
    Browning, JL
    Mackay, F
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2000, 192 (10) : 1453 - 1465
  • [2] Origins and functions of B-1 cells with notes on the role of CD5
    Berland, R
    Wortis, HH
    [J]. ANNUAL REVIEW OF IMMUNOLOGY, 2002, 20 : 253 - 300
  • [3] Impaired IgA class switching in APRIL-deficient mice
    Castigli, E
    Scott, S
    Dedeoglu, F
    Bryce, P
    Jabara, H
    Bhan, AK
    Mizoguchi, E
    Geha, RS
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (11) : 3903 - 3908
  • [4] Cheema GS, 2001, ARTHRITIS RHEUM-US, V44, P1313, DOI 10.1002/1529-0131(200106)44:6<1313::AID-ART223>3.0.CO
  • [5] 2-S
  • [6] Attenuation of apoptosis underlies B lymphocyte stimulator enhancement of humoral immune response
    Do, RKG
    Hatada, E
    Lee, H
    Tourigny, MR
    Hilbert, D
    Chen-Kiang, S
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2000, 192 (07) : 953 - 964
  • [7] ΔBAFF, an alternate splice isoform that regulates receptor binding and biopresentation of the B cell survival cytokine, BAFF
    Gavin, AL
    Aït-Azzouzene, D
    Ware, CF
    Nemazee, D
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (40) : 38220 - 38228
  • [8] Cutting edge: BAFF regulates CD21/35 and CD23 expression independent of its B cell survival function
    Gorelik, L
    Cutler, AH
    Thill, G
    Miklasz, SD
    Shea, DE
    Ambrose, C
    Bixler, SA
    Su, LH
    Scott, ML
    Kalled, SL
    [J]. JOURNAL OF IMMUNOLOGY, 2004, 172 (02) : 762 - 766
  • [9] Normal B cell homeostasis requires B cell activation factor production by radiation-resistant cells
    Gorelik, L
    Gilbride, K
    Dobles, M
    Kalled, SL
    Zandman, D
    Scott, ML
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2003, 198 (06) : 937 - 945
  • [10] The use of human CD68 transcriptional regulatory sequences to direct high-level expression of class A scavenger receptor in macrophages in vitro and in vivo
    Gough, PJ
    Gordon, S
    Greaves, DR
    [J]. IMMUNOLOGY, 2001, 103 (03) : 351 - 361